Compile Data Set for Download or QSAR
Report error Found 632 for UniProtKB: P08631
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50322535(3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-meth...)
Affinity DataIC50: 0.110nMAssay Description:Binding affinity to human HCK using KVEKIGEGTYGVVYK as substrate by radiometric hotspot kinase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50268924(CHEMBL4075002)
Affinity DataIC50: 0.257nMAssay Description:Inhibition of HCK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50268924(CHEMBL4075002)
Affinity DataIC50: 0.260nMAssay Description:Inhibition of HCK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM13216(N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyeth...)
Affinity DataKd:  0.350nMAssay Description:Binding constant for HCK kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM13216(N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyeth...)
Affinity DataKd:  0.350nMAssay Description:Binding constant for HCK kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM13216(N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyeth...)
Affinity DataKd:  0.350nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM8793(CHEMBL45177 | 7-[4-(4-methylpiperazin-1-yl)cyclohe...)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM8793(CHEMBL45177 | 7-[4-(4-methylpiperazin-1-yl)cyclohe...)
Affinity DataIC50: 0.427nMAssay Description:Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM8793(CHEMBL45177 | 7-[4-(4-methylpiperazin-1-yl)cyclohe...)
Affinity DataIC50: 0.430nMAssay Description:Inhibition of human HCK (81 to 526 residues) expressed in Sf9 insect cells after 120 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473751(US10844077, Compound I-8)
Affinity DataIC50: 0.495nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473750(US10844077, Compound I-7)
Affinity DataIC50: 0.495nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473766(US10844077, Compound I-9)
Affinity DataIC50: 0.495nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473746(US10844077, Compound I-3)
Affinity DataIC50: 0.495nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM93207(Kinase inhibitor, 5)
Affinity DataIC50: 0.5nMpH: 7.5 T: 2°CAssay Description:Fluorescence assay used for determination of catch and release efficiency. More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2013
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM8794(1-[4-(4-methylpiperazin-1-yl)cyclohexyl]-3-(4-phen...)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of HCK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473749(US10844077, Compound I-4)
Affinity DataIC50: 0.590nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473701(US10844077, Compound I-1)
Affinity DataIC50: 0.590nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473748(US10844077, Compound I-2)
Affinity DataIC50: 0.730nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM97672(US8476284, 40 | US9133201, 10 | US9181263, 9 | US9...)
Affinity DataIC50: 1nMAssay Description:For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM97672(US8476284, 40 | US9133201, 10 | US9181263, 9 | US9...)
Affinity DataIC50: 1nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction condition...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2017
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM97672(US8476284, 40 | US9133201, 10 | US9181263, 9 | US9...)
Affinity DataIC50: 1nMAssay Description:IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/6/2016
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM668506(US11963960, Example 163)
Affinity DataIC50: 1.10nMAssay Description:HCK kinase reaction (10 μL) containing 4 nM N-terminally GST-tagged HCK (75-526), purified from insect expression system, 5 μM Control AMC ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473763(US10844077, Compound II-1)
Affinity DataIC50: 1.64nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50451482(CHEMBL4208645)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473764(US10844077, Compound II-2)
Affinity DataIC50: 1.94nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM13268(CHEMBL364623 | N-(2-Chloro-6-methylphenyl)-2-[(2,6...)
Affinity DataIC50: 2nMAssay Description:inhibitory activity against Hck kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142599(US8933228, 1)
Affinity DataIC50: 2nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142600(US8933228, 2)
Affinity DataIC50: 2nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142601(US8933228, 3)
Affinity DataIC50: 2nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142607(US8933228, 14)
Affinity DataIC50: 2nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142618(US8933228, 9)
Affinity DataIC50: 2nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM473752(US10844077, Compound I-10)
Affinity DataIC50: 2.42nMAssay Description:The inhibitory activities of exemplary compounds described herein against select protein kinases.More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM163700(N-(5-((4-((4-ethylpiperazin-1-yl)methyl)-3-(triflu...)
Affinity DataIC50: 2.43nMAssay Description:The in vitro activity of the compounds described herein in inhibiting TAK1, HCK, and other kinases were obtained using an Invitrogen Select Screening...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50536679(CHEMBL4568087)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of full-length human N-terminal GST-tagged HCK expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142598(US8933228, Ref 2 | US9249125, Reference Compound |...)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50: 3nMAssay Description:The aim of this experiment is to detect the inhibitory activity of the compounds of the present invention against in vitro protein kinases using isot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142615(US8933228, 31)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142619(US8933228, 10)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142603(US8933228, 5)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142604(US8933228, 6)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142605(US8933228, 7)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50: 3nMAssay Description:Inhibition of human HCK (230 to 497 residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142610(US8933228, 26)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM50514534(CHEMBL4515441 | US12365664, Compound 18)
Affinity DataIC50: 3nMAssay Description:Inhibition of HCK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142628(US8933228, 20)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM142629(US8933228, 21)
Affinity DataIC50: 3nMAssay Description:The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 3nMAssay Description:Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetTyrosine-protein kinase HCK(Human)
Promega

Curated by ChEMBL
LigandPNGBDBM4552(CHEMBL288441 | SKI-606 | 4-[(2,4-Dichloro-5-methox...)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of HCKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2011
Entry Details Article
PubMed
Displayed 1 to 50 (of 632 total ) | Next | Last >>
Jump to: